⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of CooperVision and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
CooperVision
↗San Ramon, California, USA
CooperVision is a leading global medical device company specializing in the design and manufacture of soft contact lenses and related vision care products. It operates as a primary business unit of The Cooper Companies (NYSE: COO), focusing on vision correction, myopia management, and ocular health innovation.
The company serves eye care professionals and patients in over 130 countries, leveraging extensive research and development in optical science. CooperVision is particularly recognized for its leadership in myopia control, notably through its MiSight® 1 day contact lens, the first soft contact lens approved for slowing myopia progression in children in major global markets including the U.S., China, and Japan.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Vision Care / Contact Lenses
SIZE & FINANCIALS
Employees:10000+
Revenue:$2.5B-$4.1B
Founded:1980
Ownership:subsidiary
Status:operating
STOCK
Exchange:NYSE
Ticker:COO
Market Cap:$14.8B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Medical Device)
Modalities:Medical Devices
Active Trials:223
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:The Cooper Companies, Inc.
Subsidiaries:Paragon Vision Sciences, Inc., SynergEyes, Inc., CooperVision Manufacturing Limited
Key Partnerships:EssilorLuxottica (Joint venture for SightGlass Vision myopia management lenses)
COMPETITION
Position:Leader
Competitors:Bausch + Lomb, Johnson & Johnson Vision, Alcon, EssilorLuxottica, Carl Zeiss AG
LEADERSHIP
Key Executives:
Daniel G. McBride - President, CooperVision
Steven Robins - President, Americas
LINKS
Website:coopervision.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CooperVision. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.